Nipro to Distribute Rontis Interventional Devices in International Markets

June 2, 2015—Rontis Corporation SA recently announced that its Swiss subsidiary Rontis AG has signed an agreement with Nipro Medical Corporation, the United States subsidiary of Nipro Corporation, for the exclusive distribution of the Rontis interventional cardiology and interventional radiology device portfolio within the Asia Pacific and Oceania regions.

In 2013, Rontis and Nipro reached an agreement for the exclusive distribution and promotion by Nipro of Rontis coronary and peripheral products in Latin America. With the new agreement, Nipro intends to strengthen its presence within the region of Latin America and to expand its scope within the regions of Asia Pacific and Oceania.

Rontis develops and manufactures interventional medical devices for coronary and peripheral minimally invasive procedures, including coronary drug-eluting stents and bare-metal stents, percutaneous transluminal coronary angioplasty balloons and guidewires, peripheral stents, and peripheral balloon dilatation catheters. Rontis Corporation SA is based in Zug, Switzerland.

Nipro develops, manufactures, and markets interventional medical devices and will introduce and promote the related Rontis products in approximately 30 countries in Central America, South America, Asia Pacific, and Oceania. Nipro Corporation, which is headquartered in Osaka, Japan, engages in medical equipment, pharmaceuticals, and glass businesses.